Aquestive Therapeutics AQST
NASDAQ AQST
$4.55 +0.11 (+2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) Depreciation and Depletion (2018 - 2026)

Updated

Aquestive Therapeutics (AQST) posted Depreciation and Depletion of $136,000 for Q2 2026, down 2.9% from $140,000 a year earlier but up 20.4% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Depreciation and Depletion (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation and Depletion at Aquestive Therapeutics was $518,000, down 11.5% year-over-year; for FY2025, it was $548,000, down 14.4% from FY2024.

  • Annual Depreciation and Depletion has declined for five consecutive years, with a five-year compound annual growth rate of -30.6% (FY2020 to FY2025).
  • In prior years, Aquestive Therapeutics' Depreciation and Depletion was $640,000 in FY2024 (-44.5%), $1.15 million in FY2023 (-49.2%), $2.27 million in FY2022 (-22.0%) and $2.91 million in FY2021 (-14.2%).
  • Quarterly Depreciation and Depletion has run from a low of $113,000 in Q1 2026 to a high of $724,000 in Q3 2021 over five years.
  • On a year-over-year basis, Depreciation and Depletion has declined in each of the last ten quarters, with an average decline of 21.0% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation and Depletion in the past five years was Q4 2023, with growth of 14.2%; the weakest was Q4 2024, with a decline of 62.6%.
  • According to Business Quant data, Depreciation and Depletion for the three prior quarters was $113,000 (Q1 2026), $130,000 (Q4 2025) and $139,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Aquestive Therapeutics 571.08 Mn 111.62 Mn 9.80 Mn 136,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136,000.00
Mar 31, 2026 113,000.00
Dec 31, 2025 130,000.00
Sep 30, 2025 139,000.00
Jun 30, 2025 140,000.00
Mar 31, 2025 139,000.00
Dec 31, 2024 147,000.00
Sep 30, 2024 159,000.00
Jun 30, 2024 165,000.00
Mar 31, 2024 168,000.00
Dec 31, 2023 393,000.00
Sep 30, 2023 218,000.00
Jun 30, 2023 250,000.00
Mar 31, 2023 286,000.00
Dec 31, 2022 344,000.00
Sep 30, 2022 557,000.00
Jun 30, 2022 655,000.00
Mar 31, 2022 714,000.00
Dec 31, 2021 717,000.00
Sep 30, 2021 724,000.00
API Access

Aquestive Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=AQST&period=max&api_key=YOUR_API_KEY